Specific cognitive deficits in individuals with spinal cord injury

The article, “Patterns of cognitive deficits in persons with spinal cord injury as compared with both age-matched and older individuals without spinal cord injury,” was e-published ahead of print on December 3, 2018 by the Journal of Spinal Cord Medicine. The authors are scientists with expertise in cognitive rehabilitation and SCI rehabilitation: Nancy D. Chiaravalloti, PhD, Erica Weber, PhD, Glenn Wylie, DPhil, and Trevor Dyson-Hudson, MD, from Kessler Foundation, and Jill M. Wecht, EdD, from the James J. Peters VA Medical Center.

Individuals with chronic SCI have an increased risk for cognitive impairment, which can adversely affect recovery and overall quality of life. Concomitant brain injury fails to account for the increased risk for cognitive deficits. Multiple factors contribute to the high incidence — up to 60 percent demonstrate some degree of cognitive impairment.

Developing effective interventions is dependent on precise knowledge of the types of deficits. To explore this question, the team administered a battery of neuropsychological tests to 3 groups: 60 individuals with spinal cord injury (32 paraplegia, 28 tetraplegia), 30 age-matched controls, and 20 older healthy controls. None of the tests required motor ability; these included the WAIS-III Digit Span and Letter-Number Sequencing; Symbol Digit Modalities Test (SDMT) — oral version; California Verbal Learning Test-II; Paced Auditory Serial Addition Test (PASAT); the Wechsler Abbreviated Scale of Intelligence (WASI); Delis-Kaplan Executive Function System; and the Verbal Fluency subtest.

Significant differences were found between the SCI group and the age-matched control group, according to Dr. Chiaravalloti, director of Traumatic Brain Injury (TBI) Research, and director of the Northern New Jersey TBI Model System. “The individuals with SCI had deficits in information processing speed, verbal fluency, and new learning and memory,” noted Dr. Chiaravalloti, “while their attention and working memory were unaffected. As we had postulated, their neuropsychological profile more closely aligned with that of older healthy controls. This could be a sign of accelerated brain aging after SCI, a phenomenon that has been associated with other neurological conditions.”

“People often focus on mobility impairments associated with SCI; however, addressing cognitive deficits in this population is also critically important,” said co-author Dr. Dyson-Hudson, director of SCI Research, and director of the Northern New Jersey SCI Model System. “Future research needs to be based on broader measures of neuropsychological function. Identifying modifiable risk factors and developing targeted cognitive interventions will help restore maximal function, and support the efforts of individuals to participate in their communities and the workforce.”

Top Articles

Phytochemicals: beyond vitamins

Phytochemicals are non-nutritive chemicals in plant foods that protect plants from microbial invasions and infections.

Read More

Drinking hot tea associated with a 5-fold increased risk for esophageal cancer for some

Consuming hot tea at high temperatures is associated with an increased risk for esophageal cancer in those who also drink alcohol and smoke cigarettes, a new study finds.

Read More

People in Canada have good health, are living longer: Global Burden of Disease Study trends

Data from the Global Burden of Disease Study shows that the overall health of Canadians is good and is consistent with other similar countries, and people are living longer with diseases.

Read More

Latest News

More evidence that blood tests can detect the risk of Alzheimer’s

A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analyzed neurofilament light protein (NFL) in blood samples from patients with Alzheimer’s disease. The study suggests that the NFL concentration in the blood could be able to indicate if a drug actually affects the loss of nerve cells.

Read

Active ingredient of aconite root against peripheral neuropathic pain is identified as neoline

Aconite root is used in East Asian traditional medicines to treat pain. Since its toxicity, it is used after heat-processing for detoxifying. The present study revealed that processed aconite root could relief neuropathic pain in murine peripheral neuropathy model induced by oxaliplatin, paclitaxel, or partial ligation of the sciatic nerve (Seltzer model), and identified that its active ingredient is not benzoylmesaconine, a degraded compound of toxic mesaconitine, but neoline, a stable compound by detoxifying heat-processing.

Read

People under 40 diagnosed with type 2 diabetes face excess risk of cardiovascular disease, death

People under age 40 diagnosed with type 2 diabetes are more likely to have or die from cardiovascular disease than people of a similar age who do not have type 2 diabetes. The excess cardiovascular risks were more pronounced in younger women with type 2 diabetes and excess risk significantly decreased in those who develop diabetes much later in life.

Read

“Our bodies are our gardens - our wills are our gardeners.”

William Shakespeare